Insight

New in Cardio-Oncology: VMAT shows no early cardiac function decline for left-sided breast cancer patients

Photo taken from tendna.com

Jul 25, 2024, 21:47

New in Cardio-Oncology: VMAT shows no early cardiac function decline for left-sided breast cancer patients

Memorial Sloan Kettering Radiation Oncology shared on X:

“New in Cardio-Oncology breast cancer, Lior Braunstein:

VMAT for left-sided breast cancer RNI yielded no significant early decrement in echocardiographic parameters of cardiac function.

No patient exhibited significant LVEF changes or sustained decrements in strain.”

Source: Memorial Sloan Kettering Radiation Oncology/X

Echocardiographic functional outcomes following regional nodal irradiation for breast cancer using volumetric modulated arc therapy.

Authors: Anthony F. Yu, Charlie White, Zhigang Zhang, Jennifer E. Liu, Erin F Gillespie, Beryl McCormick, Atif J Khan, Richard M. Steingart, Simon N Powell, Oren Cahlon, Lior Z. Braunstein.

cardiac

Anthony F. Yu Atif J Khan Beryl McCormick Breast Cancer breast cancer patients cancer cardiac function Cardio-Oncology Charlie White Erin F Gillespie Jennifer E. Liu left-sided breast cancer Lior Braunstein Lior Z. Braunstein LVEF changes Memorial Sloan Kettering Radiation Oncology OncoDaily Oncology Oren Cahlon Richard M. Steingart Simon N. Powell VMAT Zhigang Zhang

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage